- The 8 States Most Likely to Legalize Marijuana Next
- Dow 18,000: Why This Market Rally May Never Happen Again
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
- BlackBerry Classic Review: A Bold Update for CrackBerry Fans
The deal U2 and its label Universal Music Group made with Apple for exclusive distribution of the band's latest album may serve as flashlight for wanderers in this recording industry.
Are broadcasts of the Met's live performances in national theaters good for opera? The answer isn't a simple yes or no.
A success touted by Peter Gelb during his term as the Metropolitan Opera's general manager has been the group's Live in HD program. But is all harmonious?
A federal judge strikes down a county ordinance that would have subjected agrochemical companies to strict oversight of pesticides and genetically modified crops.
Oil and gas company Pioneer announces earnings that show declining overall revenue, even as oil and gas revenue increases. Pioneer beat estimates on earnings per share.
Bayer CropSciences' corn seed treatments and flea and tick medicine for pets may be killing birds and bees. The company stands to lose big if the chemical is banned.
The repeal of contentious tax on carbon emissions was anticipated and the global discussion of such measure is likely to continue.
The 2014 Farm Bill moves federal policy toward a climate change risk mitigation model based on crop insurance.
Waiting behind fossil fuels for 100 years for its moment to shine in the U.S. energy economy, geothermal now plays second fiddle to newer technologies like solar and wind power.
U.S. stock futures were pointing to a lower open but shares of Nike, GoPro, and United Tech were all popping pre-market.